Home 2023

FDA review

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate
Artificial Intelligence

Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate

Alex Philippidis -
0
Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing
Drug Discovery

Circadian Clock Gene Inhibition by FDA-Approved Drugs Could Improve Scar Healing

Sophia Ktori -
0
Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus
Drug Discovery

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus

Alex Philippidis -
0
Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy
Cancer

Mechanism Underpinning “Chemo-Brain” Identified, Points to Existing Drug as Potential Therapy

Sophia Ktori -
0
Recombinant Proteins Benefit the Clinical Diagnostic Industry
Cancer

Recombinant Proteins Benefit the Clinical Diagnostic Industry

Kathy Vuksanaj -
0
Precision Medicine Marshals Its Resources
Drug Discovery

Precision Medicine Marshals Its Resources

Kathy Vuksanaj -
0
FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia
Genome Editing

FDA Approves Bluebird Bio’s Lentiviral Gene Therapy to Treat Beta-Thalassemia

Julianna LeMieux, PhD -
0
Mathematical Modeling in Biopharma: More than the Sum of Its Parts
Bioprocessing

Mathematical Modeling in Biopharma: More than the Sum of Its Parts

John Sterling -
0
Synthesis of Bacterium’s Anticancer Warhead Described
Cancer

Synthesis of Bacterium’s Anticancer Warhead Described

Sophia Ktori -
0
Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines
Cancer

Busy Bees: Hexagon Bio Combs Nature’s DNA to Unlock Next-Gen Medicines

Alex Philippidis -
0
123...10Page 1 of 10
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.